Nurocor provides a platform for digitized clinical development to help companies bring drugs to market faster.
Nurocor has raised $1.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in July 2025.
Nurocor's investors include Corporate Development Initiative.
Nurocor is headquartered in Austin, United States.
Nurocor provides a platform for digitized clinical development to help companies bring drugs to market faster.
Nurocor is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Nurocor — Funding & Investors." VCBacked, July 14, 2025, https://www.vcbacked.co/company/nurocor. Accessed August 17, 2026.
VCBacked. (2025). Nurocor — Funding & Investors. Retrieved August 17, 2026, from https://www.vcbacked.co/company/nurocor
{{cite web |title=Nurocor — Funding & Investors |url=https://www.vcbacked.co/company/nurocor |website=VCBacked |access-date=August 17, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated